Judge accepts CVS offer on Aetna while reviewing consent decree
Reuters
Published Dec 22, 2018 03:35PM ET
Judge accepts CVS offer on Aetna while reviewing consent decree
WASHINGTON (Reuters) - A U.S. federal judge reviewing an agreement between the government and CVS Health Corp (N:CVS) allowing it to buy health insurer Aetna (NYSE:AET) has indicated that he will not halt most integration between the two companies.
Judge Richard Leon said in an order on Friday evening that he would accept CVS's offer to allow Aetna to independently make critical product, pricing and personnel decisions during his review.
"Based on CVS's constructive and appropriate representations, I am satisfied that, so long as these measures remain in place, the assets involved in the challenged acquisition will remain sufficiently separate (during the review period)," Leon wrote in his order.
The Justice Department approved the $69 billion merger of CVS, a U.S. pharmacy chain and benefits manager, and Aetna in October on condition that Aetna sell its Medicare prescription drug plan business to WellCare Health Plans Inc (N:WCG). Both deals have closed.
Antitrust consent decrees are usually approved without much fanfare but Leon has said that he was "less convinced" than the government that the agreement would resolve antitrust concerns.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.